(4-Ethoxy-2,6-dimethylphenyl)boronic acid, 95.0%, 10g

1-AMINO-2-CYANOPYRROLE, 97.0%, 5g

Spiro[2.3]hexan-5-one, 97%, 1g

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate, 97.0%, 10g

3-Indoxyl-b-D-glucopyranoside trihydrate, 1g

6-Bromo-7-methyl-1H-pyrrolo[3,2-c]pyridine, 97.0%, 1g

5-chloro-3-{[(2-methylphenyl)methyl]sulfanyl}-1,2,4-thiadiazole, 95.0%, 1g

4-Bromo-6-nitroquinoline, 95.0%, 1g

GC-Kapillarsäule ROTI®Cap-FFAP, polar, L 30 m, Ø-Innen 0,25 mm, Filmd. 0,25 µm, 1 Stück

2-(2-(N-(4-(Isopropyl)phenyl)carbamoyl)phenyl)acetic acid, 98%, 10g

Ethyl 6-chloro-2-methylimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 100mg

1,3,4-Oxadiazole, 95.0%, 1g

N-(4-fluorobenzyl)-2-methyl-1-propanamine hydrochloride, 95.0%, 5g